Program overview
Context
Indication: Uterine Cervical Neoplasms
Mechanism: Unknown
Modality: Unknown
Sponsor: Women's Hospital School Of Medicine Zhejiang University
Watchlist Signal
Cadonilimab
Cadonilimab is flagged as watchlist signal because public records show operational burden. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Scores
Risk-signal summary
Registry: 3/5
Timeline: 1/5
Recruitment burden: 2/5
Results availability: 0/5
Program risk: 3/5
Evidence
Public links
https://clinicaltrials.gov/study/NCT05824494 | https://clinicaltrials.gov/study/NCT07243951
Linked trials
Trial-level signal details
| Trial | Status | Timeline | Results | Burden |
|---|---|---|---|---|
| NCT05824494 | Unknown Status Signal (UNKNOWN) | stale_update_signal | Low Signal | rare_population_signal | strict_eligibility_signal |
| NCT07243951 | Low Signal (NOT_YET_RECRUITING) | None | Low Signal | rare_population_signal |